PTC Therapeutics, Inc. PTCT Cash Flow

Ptc therapeutics, inc. (PTCT)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Cash flows from operating activities
Net loss
-292,150	-251,576	-222,229	-213,201	-180,931	-128,081	-78,481	-61,250	-69,206	-79,000	-107,066	-108,495	-129,934	-142,110	-166,262	-174,318	-173,765	-170,447	-146,768	-130,827	-117,570	-93,753	-84,370	-61,505	-50,988	-51,574	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
34,356	32,180	29,674	28,604	27,124	26,087	25,255	28,477	23,092	17,682	12,556	3,074	3,053	3,290	3,274	3,221	3,091	2,876	2,621	2,404	2,281	2,235	2,278	2,324	2,359	2,396	0	0	0
Non-cash lease expense
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in valuation of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-47	56	-21	-228	-140	-100	20	116	130	36	34	71	-38	0	0	0
Change in valuation of deferred and contingent consideration
28,100	48,360	55,300	45,800	40,500	19,340	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized loss on equity investment in Clearpoint
620	2,194	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized loss on Clearpoint convertible debt security
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
15,504	12,027	8,538	7,929	7,720	7,518	7,319	7,125	6,935	6,755	6,577	6,398	6,219	6,065	0	0	0	-	-	-	-	-	-	-	-	6,049	0	0	0
Amortization of discounts on investments, net
1,998	1,922	1,453	1,110	594	433	312	60	-231	-535	-768	-1,110	-1,462	-1,885	-2,771	-2,705	-2,625	-2,480	-1,701	-1,612	-1,679	-1,607	0	0	0	-	-	-	-
Amortization of debt issuance costs
811	694	568	548	537	524	515	504	479	433	386	340	310	302	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Share-based compensation expense
48,091	42,134	39,147	37,605	34,767	33,252	31,250	29,476	29,278	30,559	32,481	34,272	35,123	35,009	34,459	33,554	33,146	33,979	32,835	29,403	25,353	19,310	15,889	13,908	11,511	8,427	0	0	0
Unrealized foreign currency transaction losses, net
3,809	11,619	-1,123	-767	-2,106	59	1,072	2,871	2,579	459	563	-1,887	-2,022	-1,202	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Inventory
3,020	3,456	4,145	3,282	4,711	5,823	6,081	7,041	6,550	6,454	3,625	2,806	1,350	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
15,319	8,835	12,079	9,113	2,758	1,609	2,515	1,114	919	1,784	494	408	-562	-1,171	264	588	-826	2,107	1,802	1,644	4,159	2,286	704	998	1,093	760	0	0	0
Trade receivables, net
6,915	-11,525	21,029	18,862	4,580	29,589	3,890	25,870	9,680	12,203	9,801	13,124	10,910	14,842	19,360	14,718	18,852	6,907	6,731	4,256	2,340	3,487	511	-13	-108	-56	0	0	0
Deposits and other assets
12,988	17,923	15,455	10,330	11,539	1,093	444	500	626	544	609	571	492	278	206	297	19	-131	-780	-596	219	340	922	671	-26	-48	0	0	0
Accounts payable and accrued expenses
51,489	26,836	25,966	34,106	22,034	43,877	30,810	13,784	21,124	24,011	13,986	20,146	2,788	4,259	16,190	19,585	20,118	16,981	15,499	11,741	14,797	16,914	6,287	1,282	-2,735	5,183	0	0	0
Other liabilities
6,867	13,668	12,868	10,098	10,472	1,932	1,543	761	882	733	-674	-343	-1,400	-799	659	-45	-92	-92	-81	-80	-80	-80	-90	-334	-309	-285	0	0	0
Deferred revenue
-3,162	-1,388	2,162	5,821	5,679	6,514	4,692	8,069	10,296	9,469	11,468	5,543	1,865	1,526	771	634	-83	-3,307	-725	-242	-119	2,476	-2,862	-6,983	-12,033	-16,554	0	0	0
Net cash used in operating activities
-137,784	-98,639	-103,576	-84,697	-54,172	-27,641	8,790	-10,356	2,961	-10,063	-44,670	-52,976	-90,881	-103,566	-120,579	-124,265	-129,499	-124,337	-101,998	-91,273	-80,261	-57,274	-63,744	-51,885	-52,513	-46,922	0	0	0
Purchases of fixed assets
16,915	13,757	13,712	10,761	9,483	7,097	4,532	3,709	3,355	3,101	2,294	2,080	1,736	1,776	1,496	1,818	2,102	2,720	5,272	5,004	5,361	4,664	1,528	1,587	1,011	846	0	0	0
Purchase of convertible debt security
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of marketable securities
627,159	494,068	279,344	266,219	211,654	68,614	90,557	90,557	84,584	81,368	31,152	58,588	85,431	85,377	163,155	225,030	224,067	223,762	249,501	160,189	241,558	247,804	0	0	0	-	-	-	-
Sale and redemption of marketable securities
363,177	156,270	139,000	112,908	86,999	90,423	75,825	66,331	152,153	174,749	200,899	246,346	193,949	191,634	194,171	211,848	206,868	205,671	172,607	137,689	126,625	107,300	0	0	0	-	-	-	-
Acquisition of product rights and licenses
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-338,013	-387,237	-182,836	-237,378	-191,463	-42,613	-72,059	-28,674	-12,949	13,117	90,290	109,254	106,782	104,481	29,520	-15,000	-19,301	-20,811	-82,166	-27,504	-120,294	-145,168	-26,115	-196,510	-132,075	-127,829	0	0	0
Payments on long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49	84	2,871	3,964	4,996	0	0	0
Net proceeds from sale of Series Four preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	60,785	0	0	0
Proceeds from exercise of options
26,982	18,276	14,432	11,405	11,013	10,868	9,376	5,239	3,212	2,182	1,479	1,469	1,040	968	948	673	5,726	8,711	0	0	0	-	-	-	-	-	-	-	-
Proceeds from shares issued under employee stock purchase plan
-	-	-	-	-	-	-	-	-	2,468	1,362	557	557	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from public offerings
112,818	323,756	324,263	224,587	342,357	117,916	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	235,979	0	0	0	-	-	-	-
Repayment of senior secured term loan
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
405,977	613,209	614,651	237,377	356,157	131,571	129,696	126,323	44,691	44,218	42,409	41,594	1,597	968	948	146,023	151,076	154,061	272,442	126,834	121,999	237,126	118,687	115,472	250,196	187,439	0	0	0
Effect of exchange rate changes on cash
-537	-1,303	-4,075	-2,996	-7,053	-3,611	-1,352	3,484	8,866	6,199	3,523	-519	-3,557	-1,584	-315	-320	1,064	-639	0	0	0	-	-	-	-	-	-	-	-
Net increase in cash and cash equivalents
-70,357	126,030	324,164	-87,694	103,469	57,706	65,075	90,777	43,569	53,471	91,552	97,353	13,941	299	-90,426	6,438	3,340	8,274	87,839	8,048	-79,030	34,334	28,827	-132,923	65,608	12,688	0	0	0
Supplemental disclosure of cash information
Cash paid for interest
9,460	7,693	7,888	7,046	7,861	7,773	7,702	7,635	7,044	6,271	5,496	4,724	4,500	4,513	0	0	0	-	-	-	-	1	2	86	206	367	0	0	0
Cash paid for income taxes
2,079	2,109	2,595	1,838	1,794	1,583	1,404	1,525	1,399	1,101	926	1,013	746	943	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosures of non-cash information related to investing and financing activities
Unrealized gain on marketable securities
602	724	494	990	191	9	0	0	0	-	-	-	-	386	809	515	331	-202	-900	-576	-342	-457	0	0	0	-	-	-	-
Supplemental disclosure of non-cash investing and financing activity
Right-of-use assets obtained in exchange for lease obligations
28,717	17,389	16,120	11,643	11,314	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of product rights and licenses
14,209	11,434	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in carry value of preferred securities resulting from recapitalization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,391	0	0	0